SynthesisAdvances in therapy2022

The Economic Impact of Originator-to-Biosimilar Non-medical Switching in the Real-World Setting: A Systematic Literature Review.

Erin Hillhouse et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.